The global infectious disease drug market is estimated to grow at a CAGR of over 4% during the forecast period. Infectious diseases are those which are caused by different organisms such as bacteria, virus, fungi, and parasites. Some of the majorly occurring diseases that create scope for the market include Hepatitis, Pneumonia, Malaria, HIV/AIDS, Tuberculosis, E. Coli, Dengue, Influenza, Measles, and Typhoid, among others such as COVID–19, Zica, and Ebola. Influenza is a viral infection that is transmitted easily from person to person. This virus circulates globally and has the potential to infect the person of any age group. According to the Centers for Disease Control and Prevention in the US, there were 7,000 confirmed cases of the flu in 2017.

Request a free sample of our report on Global Infectious Disease Drug Market: https://www.omrglobal.com/request-sample/infectious-disease-drug-market

HIV/AIDS is one of the most chronic diseases that result in a huge number of mortalities globally. The major reason behind this is inadequate access to HIV prevention care and treatment services. However, there is a rapid decline in new HIV infections among children (around 66% since 2000), attributed to the scale-up efforts for the prevention of mother-to-child transmission. In addition, Ebola virus disease (EVD) is another infectious disease that in recent years has become a great threat to humans globally. The 2014 Ebola epidemic in West Africa caused several mortalities and attracted global attention. Thus, the increased prevalence of such severe diseases is expected to create scope for the global infectious disease drug market during the forecast period.

A full report of Global Infectious Disease Drug Market Is available at :

https://www.omrglobal.com/industry-reports/infectious-disease-drug-market



Global Infectious Disease Drugs Market Segmentation

By Disease Type

Bacterial Disease

Viral Disease

Fungal Disease

Parasitic Disease

By Treatment Type

Antibacterial

Antiparasitic

Antiviral

Antifungal

Others (Alternative Medicines)

Regional Analysis

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

India

Japan

Rest of Asia-Pacific

Rest of the World

Company Profiles

AbbVie Inc.

Allergan Plc

Amgen Inc.

Bayer AG

BioCryst Pharmaceuticals, Inc.

Boehringer Ingelheim GmbH

Bristol-Myers Squibb Co.

Eli Lilly & Co.

F. Hoffmann-La Roche Ltd.

Gilead Sciences, Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/infectious-disease-drug-market

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404